Results 221 to 230 of about 26,165 (305)

What's Needed for a Migraine Cost‐Of‐Illness Study in Aotearoa New Zealand: Review of Data Sources and Gaps

open access: yesJournal of the Royal Society of New Zealand, Volume 56, Issue 3, June 2026.
Cost of illness (COI) studies are used to quantify the economic burden of disease on health systems, employers and society, and identify where costs may be saved by improvements in disease management. Many migraine COI studies have been published internationally but none have included data from Aotearoa New Zealand (NZ), despite the known high ...
Fiona Imlach   +5 more
wiley   +1 more source

Personalized‐Context‐Aware Age Gap: A New Multi‐Omics Measurement Based on Age‐Enhanced Model AOE‐Net for Aging Acceleration and Chronic Disease Risk Prediction

open access: yesAging Cell, Volume 25, Issue 6, June 2026.
Addressing systemic biases in traditional aging clocks, we introduce PAAG, a context‐aware multi‐omics metric derived from the pre‐trained AOE‐Net. PAAG accurately captures localized aging acceleration, demonstrating superior predictive power for chronic disease risks and clinical outcomes across diverse aging populations.
Feng‐Ao Wang   +12 more
wiley   +1 more source

GLP‐1 Receptor Agonists for Obstructive Sleep Apnea: An Otolaryngologist's Prescription?

open access: yes
The Laryngoscope, Volume 136, Issue 6, Page 2406-2409, June 2026.
Alina Zgardau   +3 more
wiley   +1 more source

The Effects of Early Postnatal Alcohol Exposure on Bone Molecular Composition in a Mouse Model

open access: yesAlcohol, Clinical and Experimental Research, Volume 50, Issue 6, June 2026.
Early postnatal alcohol exposure was associated with long‐term changes in adult bone molecular composition and increased CTX‐I, indicating persistent effects on skeletal biology. Overlap with gavage‐related changes highlights the need to distinguish alcohol‐specific effects from procedural influences.
Ilknur Dursun   +2 more
wiley   +1 more source

Non-neuronal targets for migraine therapy. [PDF]

open access: yesNeurotherapeutics
Gliga O, Feliu-Soler A, Vila-Pueyo M.
europepmc   +1 more source

Respiratory Biomarkers: An Opportunity for Patient‐Centric Microsampling Approach for Treatment Optimization

open access: yesClinical and Translational Science, Volume 19, Issue 6, June 2026.
Overview of patient centric microsampling approach for monitoring respiratory biomarkers for treatment optimization. Image created in BioRender. Khan, A. (2026) https://BioRender.com/17jm5cs. ABSTRACT The clinical heterogeneity of respiratory disorders emphasizes the need for personalized approaches to prevention, diagnosis, and therapy.
Ahmar Khan   +4 more
wiley   +1 more source

Cerebrospinal Fluid and Plasma Concentrations of Atogepant in Humans

open access: yesClinical and Translational Science, Volume 19, Issue 6, June 2026.
ABSTRACT The aim of this study was to determine the cerebrospinal fluid (CSF) to plasma concentration ratio of atogepant. Healthy adult participants (N = 28) were enrolled into this phase 1, open‐label study and received atogepant 60 mg once daily for 8 days. Steady‐state atogepant concentrations were determined from CSF samples collected on Day 6 at 2
Ramesh R. Boinpally, Joel M. Trugman
wiley   +1 more source

Home - About - Disclaimer - Privacy